RecruitingACTRN12608000499381

Chlamydia Prevalence and Testing Project - a randomised controlled trial

Chlamydia prevalence and testing program targetting women aged 16 to 24 years in general practice


Sponsor

University of Melbourne

Enrollment

12 participants

Start Date

May 15, 2008

Study Type

Interventional

Conditions

Summary

To determine whether a $5 incentive payment will lead to increased chlamydia testing rates by general practitioners.


Eligibility

Sex: Both males and females

Inclusion Criteria3

  • >250 women aged 16-24 years attending the GP clinic in the past year.
  • Minimum of 2 full time equivalent (EFT) GPs per clinic.
  • An electronic medical records database.

Exclusion Criteria1

  • Clinics will be excluded from the project if they do not see more than 250 women aged 16 to 24 years per year.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

The randomisation unit is general practitioner (GP) clinic. Intervention group: GPs will receive $5 reimbursement for each eligible women aged 16 to 24 years screened for chlamydia each year. The in

The randomisation unit is general practitioner (GP) clinic. Intervention group: GPs will receive $5 reimbursement for each eligible women aged 16 to 24 years screened for chlamydia each year. The intervention will be in place for 6 months. GPs will be expected to conduct chlamydia screening during a routine consultation with an eligible patient. Screening involves requesting a chlamydia test for the patient. It should take a couple of minutes to discuss with the patient during the consultation


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12608000499381